How Much Did Twist Bioscience Raise? Funding & Key Investors

Date
May 23, 2025

Total amount raised

Latest funding date

Location

Title

LINKEDIN

Status
Verified
Use Clay's email finder to get anyone's work email in seconds.

Twist Bioscience has developed a proprietary semiconductor-based synthetic DNA manufacturing process, enabling significant advancements in fields such as drug discovery, cancer research, and human genetics. The company's innovative platform offers customizable gene synthesis solutions, variant libraries, and next-generation sequencing target enrichment, among other products.

Keep reading to explore the intricacies of Twist Bioscience's fundraising journey and the investors backing this innovative platform.

What Is Twist Bioscience?

Twist Bioscience, headquartered in South San Francisco, CA, is a leading biotechnology company specializing in DNA synthesis. They have developed a proprietary semiconductor-based synthetic DNA manufacturing process, enabling high-throughput and cost-effective DNA synthesis.

The company offers a range of products and services, including Genes, Oligo Pools, NGS solutions, Variant Libraries, Synthetic Controls, and Antibody Discovery. Twist Bioscience supports various applications such as cancer research, drug discovery, and infectious disease research, and is recognized for its innovative contributions to biotechnology.

How Much Funding Has Twist Bioscience Raised?

  1. Series A
    • Amount Raised: $9 million
    • Date: March 2014
    • Lead Investors: ARCH Venture Partners, Paladin Capital Group
  2. Series B
    • Amount Raised: $26 million
    • Date: June 2015
    • Lead Investors: Illumina, ARCH Venture Partners
  3. Series C
    • Amount Raised: $61 million
    • Date: May 2016
    • Lead Investors: Illumina, ARCH Venture Partners
  4. Series D
    • Amount Raised: $33 million
    • Date: June 2017
    • Lead Investors: Illumina, ARCH Venture Partners
  5. Series E
    • Amount Raised: $50 million
    • Date: April 2018
    • Lead Investors: Illumina, ARCH Venture Partners

Twist Bioscience has raised a total of $179 million across all funding rounds.

Key Investors

  • ARCH Venture Partners
    • Details: ARCH Venture Partners is a venture capital firm that invests in early-stage technology companies. They have a strong focus on life sciences and physical sciences.
    • Investment Focus Areas: Life sciences, physical sciences, advanced materials
    • Notable Investments: Illumina, Alnylam Pharmaceuticals, Twist Bioscience
  • Paladin Capital Group
    • Details: Paladin Capital Group is a multi-stage private equity firm that invests in companies with innovative technologies. They emphasize cybersecurity and advanced technologies.
    • Investment Focus Areas: Cybersecurity, advanced technologies, life sciences
    • Notable Investments: Digital Reasoning, White Ops, Twist Bioscience
  • Illumina
    • Details: Illumina is a global leader in DNA sequencing and array-based technologies. They provide innovative solutions for genetic research and clinical applications.
    • Investment Focus Areas: Genomics, biotechnology, healthcare
    • Notable Investments: Grail, Adaptive Biotechnologies, Twist Bioscience
  • Foresite Capital
    • Details: Foresite Capital is a healthcare and life sciences investment firm. They focus on transformative companies in the healthcare sector.
    • Investment Focus Areas: Healthcare, life sciences, biotechnology
    • Notable Investments: 10x Genomics, Denali Therapeutics, Twist Bioscience
  • Northpond Ventures
    • Details: Northpond Ventures is a venture capital firm that invests in science and technology-driven companies. They aim to support transformative innovations.
    • Investment Focus Areas: Life sciences, healthcare, technology
    • Notable Investments: Inscripta, Mission Bio, Twist Bioscience

Use Clay to Get Funding Data

Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like Twist Bioscience and gather other critical business insights. Sign up for free to start transforming your sales strategy today.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles